Phase 3 Study to Compare the Efficacy and Safety of Gemigliptin and Vildagliptin as Add-on Therapy to Metformin in People With Type 2 Diabetes Inadequately Controlled With Metformin

PHASE3CompletedINTERVENTIONAL

Enrollment

443

Participants

Timeline

Start Date

December 31, 2014

Primary Completion Date

April 30, 2016

Study Completion Date

April 30, 2016

Conditions

Type 2 Diabetes Mellitus

Interventions

DRUG

GEMIGLIPTIN LS15-0444

"Pharmaceutical form:tablet~Route of administration: oral"

DRUG

vildagliptin

"Pharmaceutical form:tablet~Route of administration: oral"

DRUG

metformin

"Pharmaceutical form:tablet~Route of administration: oral"

Trial Locations (1)

Investigational Site 03, Vladimir